{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:45:49Z","timestamp":1785725149461,"version":"3.56.0"},"reference-count":26,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Kaposi sarcoma (KS) is a rare angioproliferative malignancy driven by human herpesvirus-8 infection. Comparative real-world data on classic and AIDS-related KS from Mediterranean-endemic countries remain limited. Materials and Methods: We retrospectively analyzed 102 patients with histopathologically confirmed KS treated across five tertiary oncology centers in Turkey between January 2010 and December 2023. Demographic characteristics, clinical features, treatment patterns, and survival outcomes were compared between classic and AIDS-related KS subtypes. Results: Ninety-two patients (90.2%) had classic KS and ten (9.8%) had AIDS-related KS. The median age at diagnosis was significantly higher in the classic KS group (69 vs. 38.5 years; p &lt; 0.001). Male sex predominated in both groups (classic KS: 76.1%; AIDS-related KS: 100%; p = 0.113). AIDS-related KS presented with more advanced disease at diagnosis, with 70% classified as poor-risk by ACTG-TIS criteria versus 9.8% Stage IV by Brambilla criteria in classic KS, and more frequent extracutaneous involvement (70% vs. 8.7%; p &lt; 0.001). Paclitaxel was the most commonly used first-line agent in classic KS (42.9%), while pegylated liposomal doxorubicin predominated in AIDS-related KS (87.5%). Overall response rates were high and comparable between groups (90.7% vs. 88.9%). Median overall survival was significantly longer in classic KS (66.9 vs. 22.67 months; p = 0.012). Disease stage and lesion morphology were not significantly associated with survival in either group. Conclusions: Classic and AIDS-related KS differ substantially in clinical presentation and survival outcomes, yet demonstrate comparable chemosensitivity. Our findings in the AIDS-related Kaposi sarcoma group are preliminary and hypothesis-generating due to the small sample size, requiring confirmation in larger prospective cohorts.<\/jats:p>","DOI":"10.3390\/medicina62081483","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T01:43:27Z","timestamp":1785721407000},"page":"1483","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Demographic Characteristics, Clinical Features, and Treatment Patterns of Classic and AIDS-Related Kaposi Sarcoma: A Multicenter Real-World Study from Turkey"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8014-4140","authenticated-orcid":false,"given":"Ahmet K\u00fcr\u015fad","family":"Di\u015fli","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, K\u0131r\u015fehir Education and Research Hospital, 40100 K\u0131r\u015fehir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekir Mert","family":"Durukan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Hacettepe University, 06230 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3030-2475","authenticated-orcid":false,"given":"Esra","family":"A\u015f\u0131k","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9133-8602","authenticated-orcid":false,"given":"Ay\u015fe","family":"Nuransoy Cengiz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Erciyes University, 38039 Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"Emin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3060-377X","authenticated-orcid":false,"given":"Hasan \u00c7a\u011fr\u0131","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Ege University, 35100 \u0130zmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5869-0679","authenticated-orcid":false,"given":"\u015eafak","family":"Y\u0131ld\u0131r\u0131m Di\u015fli","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ac\u0131badem Kayseri Hospital, 38140 Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz Can","family":"G\u00fcven","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Hacettepe University, 06230 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7542-9229","authenticated-orcid":false,"given":"Serkan","family":"Ak\u0131n","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Hacettepe University, 06230 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3551-5234","authenticated-orcid":false,"given":"Oktay","family":"Bozkurt","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Erciyes University, 38039 Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyyaz","family":"\u00d6zdemir","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mevl\u00fcde","family":"\u0130nan\u00e7","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Erciyes University, 38039 Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin","family":"\u00d6zkan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Erciyes University, 38039 Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0060-9","article-title":"Kaposi sarcoma","volume":"5","author":"Cesarman","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","unstructured":"Bishop, B.N., and Lynch, D.T. (2025). Kaposi Sarcoma. StatPearls, StatPearls Publishing."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/dermatopathology11040035","article-title":"\u201cChasing Rainbows\u201d Beyond Kaposi Sarcoma\u2019s Dermoscopy: A Mini-Review","volume":"11","author":"Karampinis","year":"2024","journal-title":"Dermatopathology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/ijd.14080","article-title":"Epidemiology of Kaposi sarcoma: Review and description of the nonepidemic variant","volume":"58","author":"Vangipuram","year":"2019","journal-title":"Int. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejca.2018.12.036","article-title":"Diagnosis and treatment of Kaposi\u2019s sarcoma: European consensus-based interdisciplinary guideline (EDF\/EADO\/EORTC)","volume":"114","author":"Lebbe","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Kavak, E.E., and Urun, Y. (2025). Classical Kaposi sarcoma: An insight into demographic characteristics and survival outcomes. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-14085-0"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e43576","DOI":"10.1097\/MD.0000000000043576","article-title":"Comparison of clinical and prognostic characteristics of patients with classic and AIDS-related Kaposi sarcoma: A single-center experience","volume":"104","author":"Aydin","year":"2025","journal-title":"Medicine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clindermatol.2013.01.008","article-title":"Kaposi\u2019s sarcoma: Etiology and pathogenesis, inducing factors, causal associations, and treatments: Facts and controversies","volume":"31","author":"Ruocco","year":"2013","journal-title":"Clin. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1172\/JCI44185","article-title":"KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation","volume":"121","author":"Hassman","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.seminoncol.2014.12.027","article-title":"Kaposi sarcoma-associated herpesvirus-associated malignancies: Epidemiology, pathogenesis, and advances in treatment","volume":"42","author":"Bhutani","year":"2015","journal-title":"Semin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Hafizoglu, E., Bardakci, M., Ergun, Y., Karahan, I., Demirtas Esmer, D., Bayram, D., Kos, F.T., Alg\u0131n, E., Bal, O., and Uncu, D. (2025). Prognostic factors and long-term survival in Kaposi\u2019s sarcoma patients: Results from a 28-year retrospective cohort. Medicina, 61.","DOI":"10.3390\/medicina61040724"},{"key":"ref_12","first-page":"745","article-title":"Efficacy of chemotherapeutics on classic and non-classic Kaposi sarcoma: A single-center retrospective real-world study","volume":"21","author":"Cubukcu","year":"2021","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e32866","DOI":"10.1097\/MD.0000000000032866","article-title":"Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study","volume":"102","author":"Paksoy","year":"2023","journal-title":"Medicine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e41404","DOI":"10.1097\/MD.0000000000041404","article-title":"The efficacy of second-line chemotherapy in the management of classic and iatrogenic Kaposi sarcoma","volume":"104","author":"Khanmammadov","year":"2025","journal-title":"Medicine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/01621459.1967.10482916","article-title":"On the Kolmogorov-Smirnov test for normality with mean and variance unknown","volume":"62","author":"Lilliefors","year":"1967","journal-title":"J. Am. Stat. Assoc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","article-title":"An analysis of variance test for normality (complete samples)","volume":"52","author":"Shapiro","year":"1965","journal-title":"Biometrika"},{"key":"ref_17","unstructured":"Howell, D.C. (2011). Statistical Methods for Psychology, Wadsworth. [8th ed.]."},{"key":"ref_18","unstructured":"IBM Corp (2019). IBM SPSS Statistics for Windows, Version 26.0, IBM Corp."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Russo, I., Marino, D., Cozzolino, C., Del Fiore, P., Nerjaku, F., Finotto, S., Cattelan, A., Calabr\u00f2, M.L., Fortina, A.B., and Russano, F. (2024). Kaposi\u2019s sarcoma: Evaluation of clinical features, treatment outcomes, and prognosis in a single-center retrospective case series. Cancers, 16.","DOI":"10.3390\/cancers16040691"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Park, J., and Lee, J.E. (2024). Localized radiotherapy for classic Kaposi\u2019s sarcoma: An analysis of lesion characteristics and treatment response. Cancers, 16.","DOI":"10.3390\/cancers16183194"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2147\/OTT.S468787","article-title":"Management and future therapeutic perspectives of classic Kaposi\u2019s sarcoma: An evidence-based review","volume":"17","author":"Denaro","year":"2024","journal-title":"Onco Targets Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1097\/QAI.0000000000003557","article-title":"Real-world comparative analysis of liposomal doxorubicin versus paclitaxel as first-line therapy for Kaposi sarcoma","volume":"98","author":"Gouveia","year":"2025","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1002\/cncr.25362","article-title":"Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma","volume":"116","author":"Cianfrocca","year":"2010","journal-title":"Cancer"},{"key":"ref_24","unstructured":"World Health Organization (2025). Kaposi\u2019s sarcoma. WHO Guidelines on the Management of Advanced HIV Disease, WHO."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/bjc.1996.635","article-title":"Survival of classic Kaposi\u2019s sarcoma and risk of second cancer","volume":"74","author":"Franceschi","year":"1996","journal-title":"Br. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/cncr.10907","article-title":"Classical Kaposi sarcoma: Prognostic factor analysis of 248 patients","volume":"95","author":"Brenner","year":"2002","journal-title":"Cancer"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1483\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:17:45Z","timestamp":1785723465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["medicina62081483"],"URL":"https:\/\/doi.org\/10.3390\/medicina62081483","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}